National analysis reveals high survival rates in trauma patients receiving early ultra-massive transfusion, suggesting tailored approaches are essential.
This national analysis, spanning 5 y of data, demonstrated that 3% of adult trauma patients received early UMT. Although mortality was higher for those receiving UMT, 29% survived hospitalization. Notable survival was also observed in patients receiving > 100 units of pRBCs. Thus, the decision to continue or terminate massive transfusion protocol should involve multidisciplinary discussions among trauma providers and be tailored to individual patients, factoring in history, injuries, and resource availability.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: